Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Truist Financial
TFC
|
+$224M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$123M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$117M |
| 4 |
Bank of America
BAC
|
+$78.7M |
| 5 |
Valley National Bancorp
VLY
|
+$61.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$411M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$228M |
| 3 |
CELG
Celgene Corp
CELG
|
+$198M |
| 4 |
Walmart Inc
WMT
|
+$177M |
| 5 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$172M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.31% |
| 2 | Technology | 14.29% |
| 3 | Industrials | 13.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Healthcare | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Key Tronic
KTCC
$25.6M
| $4.76M | ﹤0.01% |
875,660
-12,054
| -1% | -$70K |
|
2627
CytomX Therapeutics
CTMX
$604M
| $4.73M | ﹤0.01% |
569,564
+162,919
| +40% | +$1.1M |
|
|
LUB
2628
DELISTED
Luby's Inc.
LUB
| $4.73M | ﹤0.01% |
2,151,312
-27,360
| -1% | -$55.4K |
|
2629
Protagonist Therapeutics
PTGX
$9.24B
| $4.73M | ﹤0.01% |
670,751
-60,554
| -8% | -$601K |
|
|
ORAN
2630
DELISTED
Orange
ORAN
| $4.72M | ﹤0.01% |
323,476
| – | – |
|
|
HWCC
2631
DELISTED
Houston Wire & Cable Company
HWCC
| $4.71M | ﹤0.01% |
1,066,814
-16,476
| -2% | -$67.6K |
|
2632
Peoples Bancorp of North Carolina
PEBK
$235M
| $4.68M | ﹤0.01% |
142,636
+2,151
| +2% | +$65.6K |
|
2633
Nature's Sunshine
NATR
$230M
| $4.65M | ﹤0.01% |
521,052
-637
| -0.1% | -$5.98K |
|
|
BGFV
2634
DELISTED
Big 5 Sporting Goods
BGFV
| $4.63M | ﹤0.01% |
1,542,072
-18,064
| -1% | -$49.4K |
|
2635
Sonida Senior Living
SNDA
$1.89B
| $4.62M | ﹤0.01% |
99,651
+149
| +0.1% | +$8.71K |
|
2636
Natural Alternatives International
NAII
$12.3M
| $4.61M | ﹤0.01% |
577,785
-6,060
| -1% | -$51.2K |
|
2637
Nomura Holdings
NMR
$30.5B
| $4.6M | ﹤0.01% |
891,316
-938
| -0.1% | -$4.53K |
|
2638
Vericel Corp
VCEL
$2.06B
| $4.59M | ﹤0.01% |
263,544
-9,205
| -3% | -$157K |
|
2639
Escalade
ESCA
$270M
| $4.58M | ﹤0.01% |
466,471
-177
| -0% | -$1.92K |
|
2640
Value Line
VALU
$362M
| $4.56M | ﹤0.01% |
157,714
-500
| -0.3% | -$12.8K |
|
2641
Comscore
SCOR
$78.4M
| $4.54M | ﹤0.01% |
45,935
+1,447
| +3% | +$99K |
|
|
IO
2642
DELISTED
ION Geophysical Corporation
IO
| $4.53M | ﹤0.01% |
521,271
-10,358
| -2% | -$89.6K |
|
2643
TransAlta
TAC
$3.78B
| $4.52M | ﹤0.01% |
631,327
| – | – |
|
2644
Thomson Reuters
TRI
$43.9B
| $4.48M | ﹤0.01% |
59,390
+379
| +0.6% | +$27.6K |
|
|
UBFO
2645
DELISTED
United Security Bancshares
UBFO
| $4.48M | ﹤0.01% |
417,461
-1,400
| -0.3% | -$14.6K |
|
|
SIEN
2646
DELISTED
Sientra, Inc.
SIEN
| $4.46M | ﹤0.01% |
49,923
+21,444
| +75% | +$1.62M |
|
|
DALN
2647
DELISTED
DallasNews
DALN
| $4.46M | ﹤0.01% |
395,286
-3,859
| -1% | -$50.9K |
|
|
OXFD
2648
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.46M | ﹤0.01% |
268,569
+112,868
| +72% | +$1.83M |
|
|
ONIT
2649
Onity Group
ONIT
$285M
| $4.45M | ﹤0.01% |
216,451
-2,083
| -1% | -$50.4K |
|
2650
Cumberland Pharmaceuticals
CPIX
$105M
| $4.43M | ﹤0.01% |
860,319
+231
| +0% | +$1.22K |
|
Similar funds
Dimensional Fund Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Dimensional Fund Advisors held 3,465 positions worth $274B, up 6.6% from $257B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.8%. Dimensional Fund Advisors opened 48 new positions and exited 85, leaving the 3,465-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q4 2019 buy was Envista: 1,368,881 shares worth $40.6M.
- Dimensional Fund Advisors added most to Truist Financial in Q4 2019, an estimated $224M increase.
- Dimensional Fund Advisors's biggest Q4 2019 reduction was Apple, cutting an estimated $411M.
- Dimensional Fund Advisors fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $228M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $274B portfolio in Q4 2019.
- Dimensional Fund Advisors opened 48 new positions and closed 85 in Q4 2019.
- Dimensional Fund Advisors's portfolio value rose 6.6% quarter-over-quarter to $274B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.